WELCOME

MESSAGE

Dear Friends,
We greatly look forward to welcoming you on behalf of the Irish Society for Immunology (ISI) and the European Federation of Immunological Societies (EFIS) to the 7th European Congress of Immunology (ECI) in Dublin from September 1st-4th 2024.

Prof. Ed Lavelle
ECI2024 Congress President

Dear Friends and Colleagues,
As President of the European Federation of Immunological Societies (EFIS), it is my pleasure to extend this invitation to you to join us in Dublin in September 2024 at the Seventh European Congress of Immunology (ECI 2024).

Prof. FEDERICA SALLUSTO
EFIS President

KEYNOTE LECTURE 1

SUNDAY, 1 SEPTEMBER 2024
AUDITORIUM | 15:15-16:15

James P. Allison
Regental Professor and Chair Department of Immunology Director, James P. Allison Institute Vice President, Immunobiology Executive Director, Immunotherapy Platform
Olga Keith Wiess Distinguished University Chair for Cancer Research

KEYNOTE LECTURE 2

MONDAY, 2 SEPTEMBER 2024
AUDITORIUM | 11:55-12:40
Tak W. Mak
Senior Scientist, Princess Margaret Cancer, University Health Network Professor, Department of Medical Biophysics and Immunology, University of Toronto
Co-Director (Scientific), Centre for Oncology and Immunology, Hong Kong
Honorary Professor, Department of Pathology, Li Ka Shing Faculty of Medicine, University of Hong Kong

KEYNOTE LECTURE 3

WEDNESDAY, 4 SEPTEMBER 2024
AUDITORIUM | 13:30-14:15

Pr. Yasmine Belkaid
Director NIAID Microbiome program
Co-Director NIH Center for Human Immunology
Chief Metaorganism Immunology Section
Chief Laboratory of Host Immunity and Microbiome, Bethesda, MD, USA

PLENARY SESSION 1

SUNDAY, 1 SEPTEMBER 2024 | AUDITORIUM | 15:15-16:15

Cecilia Garlanda PhD, Professor
The Henry H. Drake Professorial Chair of ImmunologyDepartment of Immunology & Regenerative Biology (IRB)
Weizmann Institute of Science, Israel
Associate Professor of Clinical Pathology

Judith E. Allen
Professor FRS, FRSE, FRSB, FMedSci of Immunobiology
The University of Manchester
Lydia Becker Institute for Immunology & Inflammation
Wellcome Centre for Cell-Matrix Research Faculty of Biology, Medicine & Heal

PLENARY SESSION 2

TUESDAY, 3 SEPTEMBER 2024 | AUDITORIUM | 11:55-12:55

Luke O’Neil
Inflammation Research Group School of Biochemistry and Immunology
Trinity Biomedical Sciences Institute
Trinity College Dublin

Steffen Jung
PhD, Professor
The Henry H. Drake Professorial Chair of Immunology
Department of Immunology & Regenerative Biology (IRB)
Weizmann Institute of Science, Israel

Days
Hours
Minutes
Seconds
Sign up to newsletter

Do not forget to sign up to our newsletter to get updates on ECI2024.

Related Meetings Calendar
Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.

eLife transforms research communication to create a future where a global community of researchers produces open and trusted results. Independent, not-for-profit and supported by funders, we improve the way science is practised and shared.
We aim to review significant immunology research spanning allergy, immunity and immunoregulation, inflammation and T-cell receptor signalling. To read the latest Immunology and Inflammation research reviewed by eLife, visit our website.

No matter where you are in your drug development journey, Charles River can provide you with a wide range of products, models, services, and guidance that are tailored to your specific needs. Our biologic and manufacturing services help you navigate seamlessly throughout the drug development cycle with a wide variety of comprehensive CGMP testing and manufacturing solutions including monoclonal antibodies/recombinant proteins, viral vectors, vaccines, and cell therapies. With over 40,000 tests run annually at our global biologics testing facilities and 200+ products supported; you can count on our expertise to ensure your therapy is safe, effective, and able to pass regulatory scrutiny.

Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.